Knockdown of CrkI and CrkII significantly reduced the EMT in human bladder cancer cells by decreasing expression of N-cadherin, ZEB-1, vimentin, and fibronectin and increasing E-cadherin expression. This evidence concerns the gene CRK and urinary bladder carcinoma.